Grant: Engage Grants Program
Simon Fraser University
$25,000.00
Synthesis of small molecule modulators of cancer metabolism
FY 2011-12
Summary
Cancer is a worldwide health problem and is the leading cause of death in Canada. Novel treatment strategies
are constantly being sought. Compared to normal cells, cancer cells exhibit aberrant metabolism characterized
by increased glucose uptake and rapid growth. The collaboration between Alectos Therapeutics and the Britton
research group at SFU aims to prepare and characterize a series of small-molecule drug candidates that possess
the ability to selectively disrupt tumour metabolism. This proposed ENGAGE project will capitalize on the
unique synthetic expertise and analytical characterization capabilities of the Britton group at SFU and the drug
development capabilities of Alectos Therapeutics. In collaboration, Alectos and the Britton research group will
design and optimize lead molecules for potency, selectivity, and drug-like properties using medicinal chemistry
techniques. The success of this project may lead to a better understanding of cancer cell metabolism and
ultimately, a new treatment for cancer.
Program
Engage Grants Program
Recipient
Location
British Columbia, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data
As published
Application id
428530-2011
Name nom
Britton, Robert
Department département
Chemistry
Organization id
5
Institution établissement
Simon Fraser University
Province en
British Columbia
Province fr
Colombie-Britannique
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2011
Competition year année de concours
2011
Award amount
25000
Program id
EGP
Program nane en
Engage Grants Program
Program name fr
Programme de subventions d'engagement partenariat
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
1554
Committee name en
Pacific Internal Decision Committee
Committee name fr
Comité de décision interne pour le Pacifique
Area of application code
504
Area of application group en
Manufacturing processes and products
Area of application group fr
Procédés et produits industriels
Area of application en
Human pharmaceuticals
Area of application fr
Produits pharmaceutiques administrables à l'homme
Research subject code
3701
Research subject group en
Organic chemistry
Research subject group fr
Chimie organique
Research subject en
Natural products
Research subject fr
Produits naturels
Partie
1
Nb partie
1
Application title
Synthesis of small molecule modulators of cancer metabolism
Keyword
NSERC
Application summary
Cancer is a worldwide health problem and is the leading cause of death in Canada. Novel treatment strategies
are constantly being sought. Compared to normal cells, cancer cells exhibit aberrant metabolism characterized
by increased glucose uptake and rapid growth. The collaboration between Alectos Therapeutics and the Britton
research group at SFU aims to prepare and characterize a series of small-molecule drug candidates that possess
the ability to selectively disrupt tumour metabolism. This proposed ENGAGE project will capitalize on the
unique synthetic expertise and analytical characterization capabilities of the Britton group at SFU and the drug
development capabilities of Alectos Therapeutics. In collaboration, Alectos and the Britton research group will
design and optimize lead molecules for potency, selectivity, and drug-like properties using medicinal chemistry
techniques. The success of this project may lead to a better understanding of cancer cell metabolism and
ultimately, a new treatment for cancer.